Vaidya Sane Ayur Lab

MADHAVBAUG

Price
Micro Cap
₹134 Cr.
Vaidya Sane Ayurved Laboratories Limited specializes in treating chronic ailments such as cardiac disease, diabetes, hypertension, and obesity by integrating modern technology with traditional Ayurveda practices. Their non-invasive and multidisciplinary approach to treatment has positioned them as a reliable option in India's chronic care ecosystem.
Vaidya Sane Ayurved Laboratories Limited specializes in treating chronic ailments such as cardiac d… More
Vaidya Sane Ayurved Laboratories Limited specializes in treating chronic ailments such as cardiac disease, diabetes, hypertension, and obesity by integrating modern technology with traditional Ayurveda practices. Their non-invasive and multidisciplinary approach to treatment has positioned them as a reliable option in India's chronic care ecosystem. Less
Low
81.10
52W Range
High
218
PE
67.56
Sector PE
39.09
P/B
--
Div.Yield
--
ROE
3.56%
EBIDTA
11.27
ROCE
7.0
EPS
--

Recent events

  • News

  • Corporate Actions

Vaidya Sane Ayurved Laboratories - Madhavbaug Opens First Hospital In Gujarat

Mar 18, 2025

Vaidya Sane Ayurved Laboratories Inked An MoU With Andhra Pradesh Medtech Zone

Sep 26, 2023

Vaidya Sane Ayurved Laboratories Appoints Shripad Upasani As CEO

Aug 31, 2023

Vaidya Sane Ayurved Laboratories To Issue Of Share Warrants To Strategic Investors Upto 426.5 Million Rupees

Jul 11, 2023

Vaidya Sane Ayurved Laboratories Executed Share Purchase Agreement With Shareholders Of Dynamic Remedies And UV Ayurgen Pharma

Apr 12, 2023

Events:

Announcement Date
Nov 14, 2023

Dividend

Dividend of Rs.0.25 per share
Ex Date
Sep 05, 2023
Announcement Date
May 27, 2023

Dividend

Dividend of Rs.0.25 per share
Ex Date
Nov 18, 2022
Announcement Date
Nov 10, 2022
Announcement Date
May 04, 2022

More Micro Cap Ideas

See similar 'Micro' cap companies with recent activity

Promoter Buying

Companies where the promoters are bullish

Capex

Companies investing on expansion

Superstar Investor

Companies where well known investors have invested